Carvedilol action is dependent on endogenous production of nitric oxide

American Journal of Hypertension

Volumn 19, Issue 4, 2006, Pages 419-425

  Afonso, Ricardo A ^a   Patarrao, Rita S ^a   Macedo, M Paula ^a,b   Carmo, Mota M ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Portuguese Diabetes Association   (Portugal)

Author keywords

Blood pressure; Carvedilol; Nitric oxide

Indexed keywords

CARVEDILOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPANOLAMINES; RATS; RATS, WISTAR;

EID: 33645373309     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.11.011     Document Type: Article

References (31)

1. U. Abshagen A new molecule with vasodilating and beta-adrenoceptor blocking properties J Cardiovasc Pharmacol 10 Suppl 11 1987 S23 S32
2. L. Kalinowski, L.W. Dobrucki, M. Szczepanska-Konkel, M. Jankowski, L. Martyniec, S. Angielski, T. Malinski Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux a novel mechanism for antihypertensive action Circulation 107 2003 2747 2752
3. A.J. Nichols, M. Gellai, R.R. Ruffolo Jr Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol Fundam Clin Pharmacol 5 1991 25 38
4. B.N. Prichard, B. Tomlinson Progress in antihypertensive therapy with a multiple-action drug Drugs 36 Suppl 6 1988 20 25
5. T.L. Yue, P.J. McKenna, J.L. Gu, H.Y. Cheng, R.R. Ruffolo Jr, G.Z. Feuerstein Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells Hypertension 22 1993 922 928
6. F.H. Messerli, E. Grossman β-blockers in hypertension is carvedilol different? Am J Cardiol 93 Suppl 1 2004 7 12
7. B.L. Lopez, T.A. Christopher, T.L. Yue, R. Ruffolo, G.Z. Feuerstein, X.L. Ma Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction Pharmacology 51 1995 165 173
8. O. Saijonmaa, K. Metsarinne, F. Fyhrquist Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture Blood Press 6 1997 24 28
9. H. Hu, N. Chiamvimonvat, T. Yamagishi, E. Marban Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors Circ Res 81 1997 742 752
10. S. Moncada Nitric oxide J Hypertens Suppl 12 1994 S35 S39
11. M.P. Macedo, W.W. Lautt Shear-induced modulation by nitric oxide of sympathetic nerves in the superior mesenteric artery Can J Physiol Pharmacol 74 1996 692 700
12. M.P. Macedo, W.W. Lautt Shear-induced modulation of vasoconstriction in the hepatic artery and portal vein by nitric oxide Am J Physiol 274 1998 G253 G260
13. P.M. Vanhoutte Say NO to ET J Auton Nerv Syst 81 2000 271 277
14. W.W. Lautt, X. Wang, P. Sadri, D.J. Legare, M.P. Macedo Rapid insulin sensitivity test (RIST) Can J Physiol Pharmacol 76 1998 1080 1086
15. L.J. Ignarro, J.M. Fukuto, J.M. Griscavage, N.E. Rogers, R.E. Byrns Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate comparison with enzymatically formed nitric oxide from L-arginine Proc Natl Acad Sci USA 90 1993 8103 8107
16. H. Moshage, B. Kok, J.R. Huizenga, P.L. Jansen Nitrite and nitrate determinations in plasma a critical evaluation Clin Chem 41 1995 892 896
17. A. Wennmalm, G. Benthin, A.S. Petersson Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin Br J Pharmacol 106 1992 507 508
18. F. Yang, E. Troncy, M. Francoeur, B. Vinet, P. Vinay, G. Czaika, G. Blaise Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence Clin Chem 43 1997 657 662
19. R.S. Braman, S.A. Hendrix Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection Anal Chem 61 1989 2715 2718
20. R.D. Cox, C.W. Frank Determination of nitrate and nitrite in blood and urine by chemiluminescence J Anal Toxicol 6 1982 148 152
21. P. Rhodes, A.M. Leone, P.L. Francis, A.D. Struthers, S. Moncada, P.M. Rhodes The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans Biochem Biophys Res Commun 209 1995 590 596
22. T. Rassaf, M. Feelisch, M. Kelm Circulating NO pool assessment of nitrite and nitroso species in blood and tissues Free Radic Biol Med 36 2004 413 422
23. K. Kurosaki, U. Ikeda, Y. Maeda, K. Shimada Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes J Mol Cell Cardiol 32 2000 333 339
24. E.H. Ohlstein, S.A. Douglas, C.P. Sung, T.L. Yue, C. Louden, A. Arleth, G. Poste, R.R. Ruffolo Jr, G.Z. Feuerstein Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury Proc Natl Acad Sci USA 90 1993 6189 6193
25. F. Romeo, D. Li, M. Shi, J.L. Mehta Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells modulation of Fas/Fas ligand and caspase-3 pathway Cardiovasc Res 45 2000 788 794
26. N.G. Bellenger, K. Rajappan, S.L. Rahman, A. Lahiri, U. Raval, J. Webster, G.D. Murray, A.J. Coats, J.G. Cleland, D.J. Pennell Effects of carvedilol on left ventricular remodelling in chronic stable heart failure a cardiovascular magnetic resonance study Heart 90 2004 760 764
27. M. Villarroya, C.J. Herrero, A. Ruiz-Nuno, R. de Pascual, M. del Valle, P. Michelena, M. Grau, E. Carrasco, M.G. Lopez, A.G. Garcia PF9404C, a new slow NO donor with beta receptor blocking properties Br J Pharmacol 128 1999 1713 1722
28. I.H. Zucker, H.D. Schultz, Y.F. Li, Y. Wang, W. Wang, K.P. Patel The origin of sympathetic outflow in heart failure the roles of angiotensin II and nitric oxide Prog Biophys Mol Biol 84 2004 217 232
29. R. Schulz, M. Kelm, G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res 61 2004 402 413
30. S. Sanada, K. Node, T. Minamino, S. Takashima, A. Ogai, H. Asanuma, H. Ogita, Y. Liao, M. Asakura, J. Kim, M. Hori, M. Kitakaze Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats Hypertension 41 2003 963 967
31. S. Sakai, T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, Y. Sugishita Inhibition of myocardial endothelin pathway improves long-term survival in heart failure Nature 384 1996 353 355